Business Context and Reporting Period
This Form 8-K filing by CareDx, Inc. (Delaware) was submitted on April 6, 2016, reporting events occurring on April 5 and April 6, 2016. The filing addresses a change in senior executive leadership.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The only financial figures disclosed relate to executive compensation:
- Base Salary: $325,000 annualized for the new Chief Financial Officer.
- Target Bonus: 35% of base salary.
- Equity Grant: Expected option to purchase 40,000 shares of Common Stock.
Material Changes
The primary material change is the appointment of Charles Constanti as Chief Financial Officer (CFO), effective April 6, 2016. He succeeds Ken Ludlum, who served as CFO since March 24, 2014. Mr. Constanti assumes the duties of principal financial officer and principal accounting officer.
Guidance, Outlook, and Risks
The filing contains no guidance, outlook, or management commentary regarding business operations or market conditions. No specific risks or contingencies are disclosed in this report. The employment is on an "at-will" basis, and the equity grant is subject to Board approval and continued employment.
Investor Verification Checklist
- Verify the Board of Directors' approval of the 40,000-share stock option grant.
- Confirm the vesting schedule details (25% after one year, then monthly thereafter).
- Review the attached Exhibit 10.1 (Offer Letter) for full terms of employment.
- Check for any subsequent filings regarding Ken Ludlum's departure or transition.